Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Pharma Industry News Physiomics awarded grant for PREDICT-ONC project in precision oncology Physiomics plc, a leader in mathematical modelling and drug development, announces its latest achievement: securing a grant for… byPallavi MadhirajuNovember 10, 2023